A Superior Court jury in Boston returned a verdict of $7.55 million dollars against New England Insulation, a Canton company who distributed and installed asbestos insulation material until the early 1970’s. Gerald Sylvestre, a former worker in the Public Service of New Hampshire Merrimack Power Station in Bow NH, developed pleural mesothelioma, an asbestos-caused cancer, in 2015 and is currently undergoing treatment.
Thornton Law Firm Blog
Johnson and Johnson Ordered to Pay $417 Million in Talc Ovarian Cancer Verdict
The first California trial of a plaintiff claiming her ovarian cancer was caused by Johnson & Johnson talc powder ended in a $417 million award for plaintiff Eva Echeverria.
Johnson & Johnson Hit With $57M Verdict in Pelvic Mesh Case
Johnson & Johnson’s Ethicon subsidiary was ordered to pay plaintiff Ella Ebaugh $57 million dollars for injuries she suffered from their transvaginal mesh implants. The verdict, rendered in Philadelphia Common Pleas Court, was the largest verdict in the Philadelphia mass tort litigation.
Thornton Law Firm Attorneys Named 2018 “Best Lawyers” In America
By: Michael A. Lesser, Esq. Published on September 6, 2017 Thornton Law Firm LLP is proud to announce the selection of two of the firm's attorneys to the 2018 Best Lawyers in America list. Michael P. Thornton was selected as a Best Lawyer for Mass Tort Litigation /...
J&J’s Ethicon To Pay $2.16 Million In Pelvic Mesh Verdict
A Pennsylvania state court jury awarded $2.16 million in damages to a woman with an Ethicon ProLift +M Pelvic Floor Repair System which eroded inside her body and cannot be removed. This is the fourth consecutive win for plaintiffs in the Philadelphia Court of Common Pleas, and the fourth multi-million dollar award against Johnson & Johnson and its subsidiary Ethicon. It is the first time punitive damages were not awarded.
FDA: Canagliflozin (Invokana, Invokamet) Must Add Amputation Risk Warning
The FDA has added a boxed warning to the label of diabetes drugs containing canagliflozin (Johnson & Johnson’s brand names Invokana and Invokamet) to warn that these drugs carry an elevated risk of leg and foot amputations.
CDC: U.S. Mesothelioma Deaths Continue to Rise
Mesothelioma is a type of malignant cancer that affects the thin lining of the body’s internal organs. It has been known for decades that mesothelioma is the direct result of exposure to asbestos. In response, the federal government banned many asbestos-containing products, although even today many asbestos products are still sold legally, and workers are still exposed in older structures that contain asbestos. Sadly, mesothelioma deaths continue to rise across the United States.
When Is a General Contractor Liable for Construction Jobsite Injuries?
Construction accidents often present the most complicated type of personal injury claims. It is not always easy to figure out who is liable for jobsite injuries. Many large construction projects involve multiple contractors and subcontractors, each of whom may claim they are not at fault. A recent case at UMass-Amherst presents issues of general contractor and subcontractor liability.
J&J Hit With $110 Million Verdict in Talc Ovarian Cancer Case
In the latest win for women claiming Johnson and Johnson’s talcum powder caused their ovarian cancers, a jury has awarded $110 million to a woman who developed ovarian cancer after four decades of using J&J’s Baby Powder and Shower to Shower Powder. The jury found that Johnson & Johnson ignored decades of scientific research linking talcum powder use with ovarian cancer, and failed to warn consumers of the risk.
J&J Ordered to Pay $20 Million to Victim of Defective Pelvic Mesh
A jury has returned a verdict of $20,000,000 for a New Jersey woman who has been in constant pain since receiving a vaginal mesh implant made by Johnson & Johnson’s Ethicon unit. The jury awarded $2.5 million in compensatory damages for pain, suffering, and economic loss, and $17.5 million in punitive damages to punish J&J and Ethicon for failing to warn about the risks of mesh implants.
FDA Announces Voluntary Recall of Defective EpiPens
On March 31, the U.S. Food and Drug Administration (FDA) Mylan’s voluntary recall of the popular EpiPen brand of auto-injector medical device used to treat patients with severe allergies. This announcement came nearly two weeks after a similar recall was issued for the same devices in seven other countries. The recalls were a direct response to consumer complaints that the devices failed to operate as marketed.
FDA Recalls Zimmer Biomet Shoulder: High Fracture Rate
By Marilyn T. McGoldrick, Esq. Published on April 13, 2017 Class 1 Recall The FDA has announced a Class 1 Recall of the Zimmer Biomet Comprehensive Reverse Shoulder Humeral Tray (Model 115339) following reports that the devices are fracturing at a higher rate...
